Positive Airway Pressure Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Positive Airway Pressure Devices Market size was estimated at USD 5.1 billion in 2026 and is projected to grow at a 5.23% CAGR from 2027 to 2036, exceeding USD 8.49 billion by 2036. The industry revenue for 2027 is calculated at USD 5.32 billion.
Get more details on this report
Request Free Sample ReportPositive Airway Pressure Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 49.61% share, supported by established sleep disorder diagnosis pathways, mature homecare ecosystems, reimbursement support, and consistent replacement demand for devices and accessories.
- Asia Pacific grows at 6.44% CAGR, driven by improving sleep apnea diagnosis, rising awareness, expanding healthcare infrastructure, and increasing access to respiratory care devices.
Segment Momentum
- CPAP captured a 65.67% share in 2026 due to its established role in routine sleep-disordered breathing treatment, broad clinical familiarity, and widespread adoption in home-based therapy settings.
- Respiratory Failures are the fastest-growing application because providers increasingly use non-invasive pressure support for patients requiring responsive respiratory management without immediate escalation to invasive interventions.
Market Expansion Drivers
- Increasing prevalence of obstructive sleep apnea driving sustained demand for PAP therapies.
- Rising obesity and respiratory disorder incidence expanding long-term sleep apnea treatment adoption.
- Technological advancements in portable and user-friendly PAP devices improving patient compliance rates.
Leading Market Participants
- Leading players in the positive airway pressure devices market include ResMed Inc. (United States), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Corporation Limited (New Zealand), BMC Medical Co., Ltd. (China), Drive DeVilbiss Healthcare (United States), Löwenstein Medical Technology GmbH + Co. KG (Germany), Breas Medical AB (Sweden), SEFAM (France), React Health (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.1 billion
- 2027 Estimated Market Size: USD 5.32 billion.
- Projected Market Size: USD 8.49 billion by 2036
- Growth Forecast: 5.23% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: CPAP (Product) | Obstructive Sleep Apnea (Application) | Hospitals & Clinics (End Use)
- Emerging Opportunity Segment: BiPAP (Product) | Respiratory Failures (Application) | Home Care Settings (End Use)
Market Growth Drivers and Industry Trends
Increasing prevalence of obstructive sleep apnea driving sustained demand for PAP therapies
The growing incidence and diagnosis of obstructive sleep apnea are creating a sustained need for effective respiratory support, which will drive the positive airway pressure devices market across clinical and home-care settings. PAP therapies remain an important treatment approach for maintaining airway patency during sleep and managing recurring breathing interruptions. As awareness of sleep-related breathing disorders improves and more patients seek diagnosis and long-term management, healthcare providers are increasingly incorporating PAP therapy into treatment plans, supporting demand for devices used for continuous and consistent respiratory assistance.
Rising obesity and respiratory disorder incidence expanding long-term sleep apnea treatment adoption
Rising obesity levels and the broader incidence of respiratory disorders are contributing to a larger population requiring prolonged management of sleep-related breathing conditions, strengthening the positive airway pressure devices market. Excess body weight can increase the risk of airway obstruction during sleep, while respiratory complications may further intensify the need for assisted breathing therapies. The growing requirement for ongoing treatment encourages patients and healthcare providers to adopt PAP devices for regular home use, particularly where sustained therapy and monitoring are necessary for managing sleep apnea symptoms.
Technological advancements in portable and user-friendly PAP devices improving patient compliance rates
Improvements in device portability, comfort, interface design, and ease of operation are making PAP therapy more practical for patients who require consistent treatment, thereby supporting the positive airway pressure devices market. Newer devices can be designed to accommodate daily routines while reducing barriers associated with conventional equipment, including bulkiness and complicated operation. Greater usability can encourage patients to maintain prescribed therapy over longer periods, while portable configurations also provide flexibility for treatment outside the home and during travel.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of obstructive sleep apnea driving sustained demand for PAP therapies | 1.90% | Moderate | North America, Europe | High | Near Term |
| Rising obesity and respiratory disorder incidence expanding long-term sleep apnea treatment adoption | 1.70% | Moderate | Europe, North America | High | Mid Term |
| Technological advancements in portable and user-friendly PAP devices improving patient compliance rates | 1.40% | Low | Asia Pacific, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the positive airway pressure devices market at 49.61% in 2026, supported by high awareness of sleep-related breathing disorders, established diagnostic and treatment infrastructure, and strong adoption of home-based respiratory care. The region benefits from broad access to sleep clinics, respiratory specialists, and advanced device technologies that improve treatment comfort, monitoring, and adherence. Growing recognition of obstructive sleep apnea and other breathing disorders, together with increasing preference for non-invasive treatment options, continues to reinforce demand. Established reimbursement frameworks and ongoing technological improvements in device connectivity and patient monitoring further strengthen North America's market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region, driven by improving healthcare access, rising awareness of sleep disorders, and expanding adoption of non-invasive respiratory therapies. Growing urban populations and changing lifestyle patterns are increasing attention toward sleep health, while healthcare systems are progressively investing in diagnostic capabilities and specialized respiratory services. Greater availability of positive airway pressure devices, expanding home healthcare infrastructure, and increasing patient awareness are creating favorable conditions for broader treatment adoption. The gradual integration of connected monitoring technologies is also supporting more effective long-term management and encouraging demand across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Sleep Care OptimizationGermany focuses on positive airway pressure devices that enhance clinical sleep therapy and long-term respiratory care. Providers prioritize dependable device performance, patient compliance support, and integration with established sleep medicine practices across healthcare facilities.
France 🇫🇷
Integrated Sleep ManagementFrance advances positive airway pressure device adoption through coordinated sleep disorder diagnosis and respiratory care services. Market participants focus on patient education, treatment continuity, and device solutions that support consistent therapy adherence in home settings.
Italy 🇮🇹
Accessible Home Respiratory CareItaly emphasizes practical positive airway pressure device solutions that expand access to home-based sleep apnea treatment. Healthcare providers prioritize ease of use, reliable equipment support, and effective follow-up programs that encourage sustained patient compliance.
Japan 🇯🇵
Patient Comfort EnhancementJapan prioritizes compact and user-friendly positive airway pressure devices that improve treatment acceptance for sleep-related breathing disorders. Manufacturers emphasize quiet operation, ergonomic design, and reliable long-term performance suited to routine home therapy.
South Korea 🇰🇷
Connected Respiratory CareSouth Korea promotes positive airway pressure devices with digital connectivity and remote patient monitoring capabilities. Healthcare providers increasingly value technologies that support therapy tracking, patient engagement, and efficient management of long-term respiratory treatment.
United States 🇺🇸
Home Therapy ExpansionThe U.S. positive airway pressure devices market emphasizes home-based sleep apnea management supported by connected monitoring technologies. Healthcare providers and manufacturers prioritize patient adherence, device comfort, and digital integration that improves long-term therapy outcomes.
Segment Leadership and Growth Trends
Positive Airway Pressure Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: CPAP (Largest Segment) vs BiPAP (Fastest-Growing Segment)
The positive airway pressure devices market was led by the CPAP segment in 2026, which accounted for a 65.67% share, owing to its established role in the management of obstructive sleep apnea. CPAP devices provide continuous airway pressure to help maintain airway patency during sleep, making them a widely utilized option for patients requiring consistent respiratory support. Their established clinical use, broad availability, and relatively straightforward operating principle continue to sustain demand.
BiPAP represents the fastest-growing product segment, supported by its ability to deliver different pressure levels during inhalation and exhalation. This functionality can improve comfort and respiratory support for patients who require more flexible pressure management than continuous-pressure therapy provides. Increasing attention to individualized respiratory care and the management of more complex breathing conditions is encouraging greater adoption of BiPAP devices.
Application Segment Analysis: Obstructive Sleep Apnea (Largest Segment) vs Respiratory Failures (Fastest-Growing Segment)
Obstructive sleep apnea represented the largest application segment in the positive airway pressure devices market in 2026, reflecting the widespread use of positive airway pressure therapy to prevent repeated airway obstruction during sleep. Greater awareness of sleep-related breathing disorders and increasing emphasis on diagnosis and long-term disease management are supporting demand for these devices. The established role of positive airway pressure as a non-invasive treatment option further strengthens its application in sleep apnea care.
Respiratory failures are emerging as the fastest-growing application area as healthcare providers increasingly use non-invasive ventilation to support patients experiencing inadequate respiratory function. Positive airway pressure technologies can provide respiratory assistance while potentially reducing reliance on more invasive interventions in appropriate clinical situations. Greater focus on respiratory support, home-based care, and individualized ventilation strategies is contributing to broader application in respiratory failure management.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | CPAP, APAP, BiPAP | CPAP | BiPAP |
| Application | Obstructive Sleep Apnea, Respiratory Failures, COPD | Obstructive Sleep Apnea | Respiratory Failures |
| End Use | Home Care Settings, Hospitals & Clinics, Others | Hospitals & Clinics | Home Care Settings |
Competitive Landscape and Market Positioning
Key companies in the positive airway pressure devices market:
1. ResMed Inc. (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. Fisher & Paykel Healthcare Corporation Limited (New Zealand)
4. BMC Medical Co. Ltd. (China)
5. Drive DeVilbiss Healthcare (United States)
6. Löwenstein Medical Technology GmbH + Co. KG (Germany)
7. Breas Medical AB (Sweden)
8. SEFAM (France)
9. React Health (United States)
Rising prevalence of sleep-related breathing disorders is encouraging rapid product advancement in the positive airway pressure devices market. Manufacturers are enhancing device portability, connectivity, and patient comfort through quieter systems, smart monitoring capabilities, and personalized airflow technologies. Growing integration with remote healthcare platforms is also improving therapy adherence and long-term respiratory care management.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| ResMed Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Fisher & Paykel Healthcare Corporation Limited (New Zealand) | |||||||
| BMC Medical Co. Ltd. (China) | |||||||
| Drive DeVilbiss Healthcare (United States) | |||||||
| Löwenstein Medical Technology GmbH + Co. KG (Germany) | |||||||
| Breas Medical AB (Sweden) | |||||||
| SEFAM (France) | |||||||
| React Health (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| SleepRes, Inc. | Dec-25 | SleepRes, Inc. received FDA 510(k) clearance for its Kricket PAP device, which utilizes proprietary Kairos Positive Airway Pressure (KPAP) technology. The approval expands therapeutic options for treating obstructive sleep apnea in pediatric and adult patient populations, introducing a new technological platform into the competitive landscape of positive airway pressure hardware. |
| CVC Capital | Sep-25 | CVC Capital, alongside Goldman Sachs Alternatives and Kensington Capital Partners, increased investment activity within the respiratory care sector. This influx of private equity capital signals heightened interest in the consolidation and scaling of sleep and respiratory treatment technologies, likely accelerating M&A momentum and resource availability for emerging players in the PAP device market. |
| Eli Lilly | Aug-25 | Eli Lilly received Korean regulatory approval to market Mounjaro (tirzepatide) for the treatment of obstructive sleep apnea in patients with obesity. This development introduces a significant pharmaceutical competitor to traditional mechanical PAP devices, potentially impacting patient adoption rates and altering the standard of care for patients with comorbid obesity and sleep-disordered breathing. |
| ResMed | May-25 | ResMed completed the acquisition of VirtuOx, an independent diagnostic testing facility, to expand its virtual care infrastructure. This strategic integration enhances the company’s ability to provide digital-first diagnostic services for sleep and respiratory conditions, improving patient and provider access to care pathways while strengthening its digital health ecosystem. |
| React Health | Jun-24 | React Health integrated its new IntelliPAP feature into its V+Pro, V*Home, V+C, and VC+Pro ventilator lines. The technology enables automatic adjustment of PEEP levels during noninvasive ventilation in response to detected respiratory events, enhancing the functional performance of the company’s hardware for patients with comorbid respiratory insufficiency and obstructive sleep apnea. |
| ResMed | Feb-24 | ResMed launched its AirCurve 11 series bilevel devices, integrating advanced digital health applications for data tracking and patient coaching. By leveraging its AirView and MyAir platforms, the company aims to optimize therapy compliance and user comfort, reinforcing its competitive strategy of utilizing digital ecosystems to enhance the clinical efficacy of hardware-based sleep apnea treatment. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Positive Airway Pressure Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Pediatric, Adult, Geriatric |
| Reimbursement & Payment Model | Publicly Reimbursed, Privately Insured, Self-Pay, Mixed Payment Models |
| Distribution Channel | Direct Sales, Medical Device Distributors, Durable Medical Equipment Providers, Retail & Online Channels |
Positive Airway Pressure Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Homecare Adoption Opportunity Assessment |
|
| Device Compliance and Patient Engagement Study |
|
| Digital Health Integration Roadmap |
|
Need a different cut of the data?
Request Custom ResearchHow large is the positive airway pressure devices market?
What is the expected industry size of positive airway pressure devices by 2036?
How is increasing prevalence of obstructive sleep apnea driving demand for PAP devices?
How are obesity trends and device innovations influencing long-term PAP therapy adoption?
Why does CPAP dominate the positive airway pressure devices market?
Why are respiratory failures the fastest-growing application in the positive airway pressure devices market?
Why is North America the largest market for positive airway pressure devices?
What is fueling Asia Pacific growth in PAP devices?
Who holds a significant market share in the positive airway pressure devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization